m+Medelevator.RU
← Поиск публикаций
Wiener klinische Wochenschrift · 2026

Hydrogen fluoride inhalation injury complicated by acute respiratory distress syndrome : A case report of successful management with venovenous extracorporeal membrane oxygenation and continuous renal replacement therapy.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Chen Yuqin, Chen Jianshi

Аннотация

RATIONALE: Hydrogen fluoride (HF) inhalation injury is a rare but life-threatening condition that can lead to chemical pneumonitis, acute respiratory distress syndrome (ARDS) and systemic fluoride poisoning. Currently, standardized treatment protocols for HF-induced ARDS are lacking and the optimal management strategy remains to be established.

PATIENT CONCERNS: A middle-aged male patient was discovered after inhaling 53% hydrogen fluoride gas and transferred to our hospital within 5 h, presenting with respiratory distress, hypoxemia and diffuse pulmonary opacities on computed tomography (CT).

DIAGNOSES: Severe HF inhalation injury, chemical pneumonitis, severe ARDS, acute kidney injury, distributive shock and systemic fluoride toxicity with hypocalcemia.

INTERVENTIONS: Urgent venovenous extracorporeal membrane oxygenation (VV-ECMO) with integrated continuous renal replacement therapy (CRRT), high-dose methylprednisolone, continuous calcium gluconate infusion, and electrolyte monitoring.

OUTCOMES: Oxygenation improved, pulmonary exudates resolved and the patient was weaned off ECMO. At 7‑month follow-up, lung lesions and renal function normalized with no long-term complications.

LESSONS: Early VV-ECMO supports oxygenation when conventional therapy fails, while CRRT aids fluoride elimination. Timely multimodal intervention is critical for HF-induced ARDS and renal failure outcomes.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты